These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28402800)
1. Assessment of dysglycemia risk in the Kitikmeot region of Nunavut: using the CANRISK tool. Jiang Y; Rogers Van Katwyk S; Mao Y; Orpana H; Argwal G; de Groh M; Skinner M; Clarke R; Morrison H Health Promot Chronic Dis Prev Can; 2017 Apr; 37(4):114-122. PubMed ID: 28402800 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the CANRISK tool in the identification of dysglycemia in First Nations and Métis in Canada. Agarwal G; Jiang Y; Rogers Van Katwyk S; Lemieux C; Orpana H; Mao Y; Hanley B; Davis K; Leuschen L; Morrison H Health Promot Chronic Dis Prev Can; 2018 Feb; 38(2):55-63. PubMed ID: 29443485 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the CANRISK tool in the identification of dysglycemia in a Canadian South Asian Population. Agarwal G; Jiang Y; Lemieux C; Rogers Van Katwyk S; Mao Y; Orpana H; Fong M; Morrison H Health Promot Chronic Dis Prev Can; 2018; 38(7-8):287-294. PubMed ID: 30129716 [TBL] [Abstract][Full Text] [Related]
4. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. Robinson CA; Agarwal G; Nerenberg K Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173 [TBL] [Abstract][Full Text] [Related]
5. Assessing Dysglycemia Risk Among Younger Adults: A Validation of the Canadian Diabetes Risk Questionnaire. Srugo SA; Morrison HI; Villeneuve PJ; de Groh M; Jiang Y Can J Diabetes; 2020 Jul; 44(5):379-386.e3. PubMed ID: 32033917 [TBL] [Abstract][Full Text] [Related]
6. Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes. Bahijri S; Al-Raddadi R; Ajabnoor G; Jambi H; Al Ahmadi J; Borai A; Barengo NC; Tuomilehto J J Diabetes Investig; 2020 Jul; 11(4):844-855. PubMed ID: 31957345 [TBL] [Abstract][Full Text] [Related]
7. The Usefulness of the Canadian Diabetes Risk Assessment Questionnaire (CANRISK) in Predicting Dysglycemia in Women with Histories of Gestational Diabetes. Chaudhry SN; Doyle MA; Nerenberg KA; Malcolm JC; Keely E Can J Diabetes; 2015 Dec; 39(6):491-5. PubMed ID: 26162244 [TBL] [Abstract][Full Text] [Related]
8. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort. Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192 [TBL] [Abstract][Full Text] [Related]
9. External validation of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a Peruvian hospital health care workers sample. Yovera-Aldana M; Mezones-Holguín E; Agüero-Zamora R; Damas-Casani L; Uriol-Llanos B; Espinoza-Morales F; Soto-Becerra P; Ticse-Aguirre R PLoS One; 2024; 19(8):e0299674. PubMed ID: 39110713 [TBL] [Abstract][Full Text] [Related]
10. Nova Scotia Prediabetes Project: upstream screening and community intervention for prediabetes and undiagnosed type 2 diabetes. Talbot P; Dunbar MJ Chronic Dis Inj Can; 2011 Dec; 32(1):2-11. PubMed ID: 22153171 [TBL] [Abstract][Full Text] [Related]
11. Inuit anthropometry and insulin resistance. Charbonneau-Roberts G; Young TK; Egeland GM Int J Circumpolar Health; 2007 Apr; 66(2):129-34. PubMed ID: 17515252 [TBL] [Abstract][Full Text] [Related]
12. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population. Agarwal G; Guingona MM; Gaber J; Angeles R; Rao S; Cristobal F BMC Public Health; 2019 Aug; 19(1):1169. PubMed ID: 31455247 [TBL] [Abstract][Full Text] [Related]
13. Piloting the CANRISK tool in Vancouver Coastal Health. Papineau D; Fong M Chronic Dis Inj Can; 2011 Dec; 32(1):12-8. PubMed ID: 22153172 [TBL] [Abstract][Full Text] [Related]
14. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects. Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170 [TBL] [Abstract][Full Text] [Related]
15. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population. Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977 [TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: the International Polar Year Inuit Health Survey for Adults 2007-2008. Egeland GM; Cao Z; Young TK CMAJ; 2011 Jun; 183(9):E553-8. PubMed ID: 21555386 [TBL] [Abstract][Full Text] [Related]
17. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes. O'Brien MJ; Bullard KM; Zhang Y; Gregg EW; Carnethon MR; Kandula NR; Ackermann RT J Gen Intern Med; 2018 Jul; 33(7):1100-1108. PubMed ID: 29651678 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria. Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207 [TBL] [Abstract][Full Text] [Related]
19. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients. O'Brien MJ; Lee JY; Carnethon MR; Ackermann RT; Vargas MC; Hamilton A; Mohanty N; Rittner SS; Park JN; Hassan A; Buchanan DR; Liu L; Feinglass J PLoS Med; 2016 Jul; 13(7):e1002074. PubMed ID: 27403739 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of self-reported questionnaire data to screen for dysglycemia in young adults: Findings from the US National Health and Nutrition Examination Survey. Srugo SA; de Groh M; Jiang Y; Morrison HI; Villeneuve PJ Prev Med; 2019 Mar; 120():50-59. PubMed ID: 30639079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]